FORDYCE MARSHALL (President and CEO) sold 23.3% of their position (46.25K shares) of VERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.96M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 7/9/2026ACC: 0001859453-26-000010
DirectorOfficer· President and CEO
Since May 2021
-46.25K
Net shares
Net seller
$1.96M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
46.25K disposed
Non-Derivative Transactions4
Class A Common Stock
Direct
Shares
−1K
Price / share
$40.78
Trade value
$40.78K
% of position
0.5%
7/7/2026
198.24K→197.24K
Class A Common Stock
Direct
Shares
−32.55K
Price / share
$42.07
Trade value
$1.37M
% of position
16.5%
7/7/2026
197.24K→164.69K
Class A Common Stock
Direct
Shares
−10.50K
Price / share
$42.86
Trade value
$450.01K
% of position
6.4%
7/7/2026
164.69K→154.19K
Class A Common Stock
Direct
Shares
−2.20K
Price / share
$43.59
Trade value
$95.91K
% of position
1.4%
7/7/2026
154.19K→151.99K
Total
Net shares
−46.25K
Net value
-$1.96M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 7/7/2026 | S · Sale | −1K | $40.78 | $40.78K | 0.5% | 198.24K | 197.24K |
| Class A Common Stock Direct | 7/7/2026 | S · Sale | −32.55K | $42.07 | $1.37M | 16.5% | 197.24K | 164.69K |
| Class A Common Stock Direct | 7/7/2026 | S · Sale | −10.50K | $42.86 | $450.01K | 6.4% | 164.69K | 154.19K |
| Class A Common Stock Direct | 7/7/2026 | S · Sale | −2.20K | $43.59 | $95.91K | 1.4% | 154.19K | 151.99K |
| Total | −46.25K | -$1.96M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Class A Common Stock
IndirectShares owned122.95K
Class A Common Stock
IndirectShares owned99.08K
Total
222.03K indirect222.03K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 122.95K | Indirect |
| Class A Common Stock | 99.08K | Indirect |
| Total | 222.03K | 222.03K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported